PARP Inhibitor–Based Combinations to Improve Patient Outcomes in Prostate Cancer: An Evidence-Based Global Perspective

Download All
Learn about PARP inhibitor–based combination therapy in prostate cancer in this expert-authored online activity with downloadable slides, podcasts and a ClinicalThought.
Charles J. Ryan, MD

Downloadable Slideset

Download this slideset for expert insight on the latest evidence on PARP inhibition and novel PARP inhibitor combination therapy in advanced prostate cancer.

Charles J. Ryan, MD Released: April 12, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings